Free Subscription to Health Content Weekly Perspective
Categories
- Advertising
- Clinical tools
- Clinical Trials
- CMS, HHS
- Conferences
- Consumer Health
- Databases
- DrugInfo
- EBM
- EHRs
- Elsevier
- Eprescribing
- Google Health
- Health Grades
- Health2.0
- Healthcare Publishing
- HealthCentral Network
- HealthIT
- Healthline
- HIE
- Infocommerce
- infodemiology
- Licensing
- long-term care
- medical devices
- Medical Research
- Medical Search
- Medical Tourism
- Microsoft HealthVault
- MU
- newspapers
- open data
- Payers
- PBM
- Personalized Medicine
- Pharma
- Physician directories
- Physicians
- Point-of-care Applications
- publishing
- RCM
- RevolutionHealth
- Sermo
- Social networking
- UpToDate
- WebMD
- Wiley-Blackwell
- Wolters-Kluwer
Archives
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
Blogroll
Headline Commentary July 14-19
- Posted July 19th 2009
- by Janice
Netsmart, an enterprise software vendor to behavioral & public health providers, acquires Crown Software. Crown provides pharmacy management s/w that integrates with EHRs.
Article describes how sponsorship by pharma or other commercial entities leads to bias in clinical trial results and in published journal articles. An unintended consequence of open access, where research org funds publication?
A short, concise piece that provides some good examples of how newspaper/news publishers could create new revenue streams. Good examples, including some I’ve used in the past (post original documents & databases, better repurposing of archives, special editions, and more).
Big pharma is increasing subsidizing co-pays for their drugs in order to retain customer loyalty. Co-pays were put in place to help persuade consumers to focus on costs and compare drugs.
University presses looking at forming consortium program to promote ebook sales.
ACS provides more detail about its new print format (landscape w/ 2 pages on each sheet) and changes to pricing, which eliminates print discount.
Good examples of how healthIT can add efficiency, but physician author cautions that entering data takes time. This doc is part of Kaiser Permanente, which is frequently held up as an example of effective use of electronic health records. Problem is, KP is an integrated system, which makes it much easier to enforce interoperability and usage.
Excellent article on how crowdsourcing to harness innovative ideas can work when there’s some structure and focus.
Good roundup of providers and related info about trend toward elderly staying in their homes and retrofitting with safety gear. Role of occupational therapist growing for this purpose, too.
Good commentary on top web sites for consumer health info.
Example of industry information company adding value through data-analytics.
Transcript and video interview with Obama, discussing evidence-based medicine & health reform.
Article provides breakdown of downloaded apps by category & within category, by free & paid.
Jim Clark, founder of SGI and Netscape, and later Healtheon (which merged with WebMD) speaks somewhat acerbicly about state of innovation & prospects for US in global business. Digs about lack of workable electronic health records, too.
Lewin Group, a health care policy research firm, launches new center for comparative effectiveness research (CER). note, Lewin won an HHS bid recently to construct CER framework. Lewin will incorporate longitudinal patient data (de-identified)from Ingenix, it’s parent company.
Pharma & biotech look to fare better than initially expected in health reform bill. Biotechs, as previously reported, will likely get 12 years exclusivity, vs. 7 originally proposed by Obama. Pharma wins on issues of drug importation & Medicare drug prices.
Josh Seidman’s very clear exposition of why needs of clinicians and patients have to be central to efforts to define meaningful use of electronic health records. Sadly, these voices are mostly absent from the discussions (apart from clinicians with IT roles in large provider organizations).
John Halamka provides concise update to meaningful use (MU) definition that came out of this week’s HIT Policy Committee meeting.
Robert Wood Johnson University Hospital (RWJ) loses motion to dismiss copyright & trademark infringement suit from HealthGrades for misuse of its ratings info, although RWF is mostly successful in motion to dismiss breach of contract claims. RWJ used copyrighted HealthGrades ratings in press releases & articles.
More concern about the ethics of folks behind Clinical Reader, a company that provides an interface to collections of clinically-relevant medical info.
Post provides some historical context on how medical research in academic settings has changed in age of Google. But, the adage “plus ca change, plus c’est la meme chose” almost always applies, esp. when it comes to business models/pricing models. Note, I worked at Dialog from ‘85-’95 during the time when CDRom was introduced.
Wow, when I have referred to “intermediaries” as a key category in the health content supply chain, entertainment companies weren’t top of mind. But, after reading the description of this program at the USC Annenberg Norman Lear Center, it makes sense. TV programs and movies have a lot of influence on the health literacy of our population. It’s important that the writers, editors & all parties in media understand where to find authoritative info & learn how to interpret it.
Princeton bioethicist, Peter Singer, writes on why we can’t afford to offer the most expensive new treatments to everyone. I’ve seen some strong reaction to his article, but to those who are “disturbed” by Singer’s premise, would you prefer involuntary bankruptcy and lifelong poverty to patients who are given treatements that they cannot afford? That’s what we have now–along with rampant price increases.
Jim Spanfeller resigns from Forbes, where he has led digital efforts for past 9 years, to start his own media management firm. Forbes had fared better than other business publications in part due to its more aggressive online strategies, but in my opinion, their online presense lacked cohesion and proper design. In print, Forbes remains a notch above most business pubs and can still leverage its readership.
Sagient Research will provide assessments, forecasts & approval timelines on clinical stage drugs for new “Forecast” module of Thomson Pharma Partnering. Sagient produces the BioMedTracker research service.
3 PE groups resubmitted bids for Springer at request of Candover & Cinven. New bids slightly higher (>400 M Euros vs. 350-380M Euros of 1st round), but still short of the hoped for 500 M Euro bid for up to 40% of Springer. PEHub rightly points out that Candover & Cinven recapitalized Springer 3 times and paid themselves healthy dividends each time.
Major insurers/payers are backing pilot medical home projects in NH, Maine, Colorado & NY. “Medical Home” is an awkward term for coordinated care that includes more focus on prevention.
Recent Posts
- Consequences of Market Concentration in Healthcare
- Today’s Health Content Headlines
- TEDxBoston: It’s Not Just About Information
About InfoCommerce Group
Leave a Reply